Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice
- PMID: 15661360
- DOI: 10.1016/j.molbrainres.2004.09.012
Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice
Abstract
We have studied binding parameters (Kd, Bmax) of [3H]N-methylscopolamine ([3H]NMS) in various brain regions and spinal cord of wild-type (WT) and muscarinic acetylcholine receptor (mAChR) subtype (M1-M5) knockout (KO) mice. In the M1-M4 KO mice, the number of [3H]NMS binding sites (Bmax) was decreased throughout the central nervous system (CNS) with significant regional differences. Our results collectively suggest that M1 receptor was present in a relatively high density in the cerebral cortex and hippocampus, and the densities of M1 and M4 subtypes were highest in the corpus striatum. M2 receptor appeared to be the major subtype in the thalamus, hypothalamus, midbrain, pons-medulla, cerebellum and spinal cord. These findings may contribute significantly not only to the further understanding of the physiological roles of mAChR subtypes in the central cholinergic functions, but also to the development of selective therapeutic agents targeting specific subtype.
Similar articles
-
Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.Synapse. 1993 Aug;14(4):283-96. doi: 10.1002/syn.890140406. Synapse. 1993. PMID: 8248852
-
Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.Mol Pharmacol. 1994 Dec;46(6):1028-35. Mol Pharmacol. 1994. PMID: 7808421
-
Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.Mol Pharmacol. 1987 Jul;32(1):91-9. Mol Pharmacol. 1987. PMID: 3600616
-
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.Prog Brain Res. 2004;145:59-66. doi: 10.1016/S0079-6123(03)45003-6. Prog Brain Res. 2004. PMID: 14650906 Review.
-
Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.Auton Autacoid Pharmacol. 2006 Jul;26(3):219-33. doi: 10.1111/j.1474-8673.2006.00368.x. Auton Autacoid Pharmacol. 2006. PMID: 16879488 Review.
Cited by
-
Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.Int Neurourol J. 2012 Sep;16(3):107-15. doi: 10.5213/inj.2012.16.3.107. Epub 2012 Sep 30. Int Neurourol J. 2012. PMID: 23094215 Free PMC article.
-
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon-induced seizures.Pharmacol Res Perspect. 2015 Feb;3(1):e00100. doi: 10.1002/prp2.100. Epub 2014 Nov 7. Pharmacol Res Perspect. 2015. PMID: 25692018 Free PMC article.
-
The Cholinergic System as a Treatment Target for Opioid Use Disorder.CNS Drugs. 2018 Nov;32(11):981-996. doi: 10.1007/s40263-018-0572-y. CNS Drugs. 2018. PMID: 30259415 Free PMC article. Review.
-
Lateral hypothalamic-induced antinociception may be mediated by a substance P connection with the rostral ventromedial medulla.Brain Res. 2008 Jun 12;1214:40-9. doi: 10.1016/j.brainres.2008.03.051. Epub 2008 Apr 8. Brain Res. 2008. PMID: 18457815 Free PMC article.
-
Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice.Br J Pharmacol. 2009 Apr;156(7):1147-53. doi: 10.1111/j.1476-5381.2009.00113.x. Br J Pharmacol. 2009. PMID: 19378377 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials